Specialties

As epidemiologic evidence suggests diabetic men have a slightly lower prostate cancer risk than non-diabetic men.

A new study sheds additional light on how erectile dysfunction (ED) interacts with diabetes. The study is another step in uncovering the link between the two disorders, and may lead to improved efficacy in erectile dysfunction treatments.

54 Million Americans have pre-diabetes and according to a new study, periodontal disease can be a possible cause.

A new study appears to suggest that treating periodontal disease can improve endothelial dysfunction, with investigators showing that aggressively treating periodontal disease, a potential source of low-grade inflammation, results in a long-term improvement in vascular function.

Adding a single daily dose of glarine to oral antidiabetic agents is an effective treatment in controlling blood sugars.

A new tool is developed to identify patients who are most at risk for chronic kidney disease (CKD).

Periodontal destruction can start very early in life in diabetes and becomes more prominent as children become adolescents.

Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.

Preliminary results from a phase III withdrawal-design trial with lacosamide in patients with painful diabetic neuropathy show that lacosamide was statistically significant over placebo in reducing pain scores. SCHWARZ PHARMA plans for regulatory submission during the second half of 2007

Periodontitis — an infection of the gums that destroys the tissue and bone supporting the teeth — is associated with the development of kidney disease and end-state renal disease (ESRD) in patients with type 2 diabetes, doctors report.